SynthesisJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer.

Joseph A Sparano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.